510(k) · Cleared
ClearedTomey Cornea/Anterior Segment OCT (CASIA2)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Tomey Corporation · OBO Tomography, Optical Coherence
Cleared on Jul 18, 2025 as substantially equivalent to K213265 (Tomey Corporation, 2022) after a 143-day review. Its family tree reaches back 10 generations to 2002.
- Decided
- Jul 18, 2025
- Review
- 143 days
- Class
- Class II
- Product code
- OBO
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 10 generations to K012727 (2002). 17 ancestors in all, the oldest K955442 (1996). No later device cites it as a predicate yet.
- Root · 10 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
- 6 generations between
- 3 generations backK153080 RTVue XR OCT Avanti with AngioVue SoftwareOptovue, Inc. · 2016
- 2 generations backK180660 AvantiOptovue, Inc. · 2018
- 1 generation backK213265 Tomey Cornea/Anterior Segment OCT CASIA2Tomey Corporation · 2022
- This deviceK250553 Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 2025
Show all 10 generations
- Root · 10 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
- 9 generations backK030433 Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc. · 2003 · Recalled
- 8 generations backK033123 Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 2004 · Recalled
- 7 generations backK063343 Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc. · 2006
- 6 generations backK071250 CA, Model: CamOptovue, Inc. · 2007
- 5 generations backK101505 Rtvue Model Rtvue 100Optovue, Inc. · 2010 · Recalled
- 4 generations backK120238 Rtvue XR OctOptovue, Inc. · 2012
- 3 generations backK153080 RTVue XR OCT Avanti with AngioVue SoftwareOptovue, Inc. · 2016
- 2 generations backK180660 AvantiOptovue, Inc. · 2018
- 1 generation backK213265 Tomey Cornea/Anterior Segment OCT CASIA2Tomey Corporation · 2022
- This deviceK250553 Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 2025
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −10 | K012727 | Humphrey OCT3 | Carl Zeiss Ophthalmic Systems, Inc. | 2002 | — |
| −9 | K030433 | Stratusoct with RNFL Normative Database | Carl Zeiss Meditec, Inc. | 2003 | 1 |
| −8 | K033123 | Stratusoct with RNFL & Macula Normative Database | Carl Zeiss Meditec, Inc. | 2004 | 1 |
| −7 | K063343 | Bioptigen Spectral Domain Ophthalmic Imaging System | Bioptigen, Inc. | 2006 | — |
| −6 | K071250 | CA, Model: Cam | Optovue, Inc. | 2007 | — |
| −5 | K101505 | Rtvue Model Rtvue 100 | Optovue, Inc. | 2010 | 1 |
| −4 | K120238 | Rtvue XR Oct | Optovue, Inc. | 2012 | — |
| −3 | K153080 | RTVue XR OCT Avanti with AngioVue Software | Optovue, Inc. | 2016 | — |
| −2 | K180660 | Avanti | Optovue, Inc. | 2018 | — |
| −1 | K213265 | Tomey Cornea/Anterior Segment OCT CASIA2 | Tomey Corporation | 2022 | — |
| 0 (this device) | K250553 | Tomey Cornea/Anterior Segment OCT (CASIA2) | Tomey Corporation | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1999 | 1 | 0 |
| 2003 | 1 | 0 |
| 2005 | 1 | 0 |
| 2006 | 1 | 0 |
| 2011 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OBO device
- #1 K250868 SPECTRALIS HRA+OCT and variantsscore 16.2 · 14 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K213265 | Tomey Cornea/Anterior Segment OCT CASIA2Summary page 5…) The CASIA2 is substantially equivalent to the following legally marketed device: 510(k) Number Trade name Product code K213265 Cornea/Anterior Segment OCT CASIA2 OBO 3. Device Description Summary (21.CFR 807.92(a)(4) The T… | 2022 |
| † | K082891 | Lenstar, Model LS900 | 2009 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 23 years and passes through 5 companies; a new generation was cleared every 2.6 years on median.
- 5 of the 17 ancestors have a recall of any class.
How does its category compare?
All OBO devicesOBO Tomography, Optical Coherence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · OBO
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · OBO
125in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OBO
1in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · OBO
4in 2025
MAUDE reports naming product code OBO, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 2 | — | 0 | 0 |
| 2009 | 4 | 151 | 0 | 0 |
| 2010 | 2 | — | 1 | 0 |
| 2011 | 2 | — | 2 | 0 |
| 2012 | 3 | 269 | 2 | 0 |
| 2013 | 2 | — | 0 | 2 |
| 2014 | 3 | 152 | 0 | 0 |
| 2015 | 1 | — | 0 | 0 |
| 2016 | 4 | 125 | 0 | 1 |
| 2017 | 4 | 118 | 0 | 0 |
| 2018 | 6 | 87 | 1 | 1 |
| 2019 | 5 | 249 | 0 | 0 |
| 2020 | 2 | — | 0 | 0 |
| 2021 | 1 | — | 1 | 1 |
| 2022 | 2 | — | 1 | 0 |
| 2023 | 7 | 262 | 0 | 3 |
| 2024 | 8 | 157 | 0 | 3 |
| 2025 | 3 | 125 | 0 | 4 |
| 2026 | 2 | — | 1 | — |
What is it indicated for?
CASIA2 is a non-contact, high-resolution tomographic and biomicroscopic device intended for the in vivo imaging and measurement of ocular structures in the anterior segment. CASIA2 measures corneal thickness, anterior chamber depth and lens thickness.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K250553 · printed Nov 5, 2026
Cite this page
510(k) Report. “K250553: Tomey Cornea/Anterior Segment OCT (CASIA2).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K250553
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026